Works matching IS 02692813 AND DT 2020 AND VI 51 AND IP 3
Results: 15
Editorial: inaccuracies in attribution of symptoms due to gluten—not just in those with self‐reported noncoeliac gluten sensitivity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 402, doi. 10.1111/apt.15620
- By:
- Publication type:
- Article
Editorial: histologic normalisation in ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 399, doi. 10.1111/apt.15617
- By:
- Publication type:
- Article
Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check‐up clinic population.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 388, doi. 10.1111/apt.15626
- By:
- Publication type:
- Article
Volatile organic compounds in breath can serve as a non‐invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 334, doi. 10.1111/apt.15622
- By:
- Publication type:
- Article
Editorial: histologic normalisation in ulcerative colitis. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 401, doi. 10.1111/apt.15621
- By:
- Publication type:
- Article
Editorial: inaccuracies in attribution of symptoms due to gluten—not just in those with self‐reported noncoeliac gluten sensitivity. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 403, doi. 10.1111/apt.15629
- By:
- Publication type:
- Article
Editorial: interventions in infantile colic – can efficacy be attributed to treatment or to time? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 398, doi. 10.1111/apt.15627
- By:
- Publication type:
- Article
Letter: diarrhoea in obese patients—a new nosographic entity?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 405, doi. 10.1111/apt.15613
- By:
- Publication type:
- Article
Plasma metabolic alterations in patients with severe obesity and non‐alcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 374, doi. 10.1111/apt.15606
- By:
- Publication type:
- Article
Editorial: interventions in infantile colic – can efficacy be attributed to treatment or to time?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 397, doi. 10.1111/apt.15599
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: risk of adverse pregnancy‐related outcomes in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 320, doi. 10.1111/apt.15587
- By:
- Publication type:
- Article
Hepatitis C eradication with direct‐acting anti‐virals reduces the risk of variceal bleeding.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 364, doi. 10.1111/apt.15586
- By:
- Publication type:
- Article
Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 347, doi. 10.1111/apt.15568
- By:
- Publication type:
- Article
HLADQA1*05 genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 356, doi. 10.1111/apt.15563
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 3, p. 317, doi. 10.1111/apt.15339
- Publication type:
- Article